May 4, 2016


Acelity L.P. Inc. Reports First Quarter Financial Results for 2016

Acelity L.P. Inc.:

First Quarter Financial Highlights

  • Revenue for the first quarter of 2016 of $451.4 million, grew 1.6% as reported on a GAAP basis and 3.0% on a constant currency basis, from the prior-year period
  • Revenue from Advanced Wound Therapeutics ("AWT") grew 0.5% as reported on a GAAP basis and 2.1% on a constant currency basis, led by solid volume growth in advanced wound devices compared to the prior-year period
  • Revenue from Regenerative Medicine ("RM") grew 5.5% as reported on a GAAP basis and 5.8% on a constant currency"......

    Continue Reading >

May 3, 2016


Algerian Abdelmalek Sayah elected Secretary general of IFBDO

Algerian Abdelmalek Sayah has been elected Secretary General of the International Federation of Blood Donors Organizations (IFBDO), said Monday the Algerian Blood Donor Federation in a statement.

Sayah, member of the federal bureau of the Algerian Federation, was elected unanimously during the General IFBDO Assembly, whose works were held on Friday and Saturday in the"...

Continue Reading >

May 2, 2016


Algeria has all capacities for success of national anti-cancer plan

Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf underlined that Algeria has all the capacities for the success of the national anti-cancer plan.

In a message addressed to the participants of the 25th national day of information and training on cancer, read Saturday in Tissemsilt by director of community health at the ministry Fawzi Benachenhou,"...

Continue Reading >

May 1, 2016


Several achievements in Algeria's health sector, says UN official

UN Special Rapporteur on the Right to Health Dainius Puras said Saturday in Algiers that Algeria has made a "lot of achievements" in the health sector, including free healthcare.

"There have been many achievements in Algeria, including Algerian people's free access to healthcare," Puras told reporters following his meeting with the secretary general of the National"...

Continue Reading >

April 30, 2016


Ora® Appoints David Hollander, M.D., M.B.A., as Chief Medical Officer

Meet Ora’s New Chief Medical Officer at ARVO

Ora, Inc., the world’s leading partner for ophthalmic pharmaceutical and device development, announced today the appointment of David A. Hollander, M.D., M.B.A., as Chief Medical Officer and Senior Vice-President. Dr. Hollander most recently served as Therapeutic Area Head and Vice President of clinical development at Allergan®, responsible for global strategy and clinical development"...

Continue Reading >

April 30, 2016


Oran: Fifty participants at 2nd Optics, Eyewear Fair

ORAN- A total of fifty international exhibitors are taking part in the 2nd Optics and Eyewear Fair “Expo Vision 2016,” held since Thursday in Oran.

The event’s organizer Kacem Benaffen, manager of the company "BC communication," said that the fair, placed under the theme “Another view on optics,” aims at professionalizing the corporation of the optics and serving as a framework to present the latest innovations.


Continue Reading >

April 28, 2016


Phase 3 Trial Results for First Oral Proteasome Inhibitor NINLARO (ixazomib) Published in The New England Journal of Medicine

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that results from the international, randomized, double-blind, placebo-controlled TOURMALINE-MM1 Phase 3 clinical study, evaluating once-weekly oral NINLARO® (ixazomib) capsules plus lenalidomide and dexamethasone versus placebo plus lenalidomide-dexamethasone in patients with relapsed and/or refractory multiple myeloma, have been published in the prestigious New England Journal of Medicine (NEJM). NINLARO was recently approved by the U.S. Food and Drug Administration (FDA), based on the pivotal"......

Continue Reading >

April 28, 2016


Biogen Appoints Michael Ehlers Executive Vice President, Research and Development

Biogen (NASDAQ: BIIB) today announced the appointment of Michael Ehlers, M.D., Ph.D., as executive vice president, Research and Development.

Dr. Ehlers will oversee Biogen’s global Research, Drug Discovery, Clinical Development, and Medical Affairs functions, defining the strategic direction for the company’s R&D organization and leading its efforts to develop therapies for patients with few or no treatment options. Dr. Ehlers will report to George Scangos, Ph.D., chief executive officer, and will be a member of the Biogen management team. He will begin his tenure at Biogen in late May.


Continue Reading >

April 28, 2016


Little Life Hack, “Berry” Big Benefit

Women today do it all and don’t have time to be slowed down by pesky infections like urinary tract infections (UTIs). Luckily, there’s a simple solution to stave off that unwelcome sensation, and it’s been around for nearly a century – cranberry juice. Chock-full of powerful nutrients, cranberries have unique anti-bacterial properties that help prevent the bacteria that cause UTIs from sticking in the body. That’s great news for your busy schedule, and even better for you!


Continue Reading >

April 24, 2016


Brucellosis outbreak in Algeria exceeds 800 people year to date

Health officials in Algeria are investigating a large human brucellosis outbreak in Ghardaia province in the eastern part of the country. According to an Algeria Press Service report (computer translated), 819 were diagnosed since the beginning of the year, a number equal to the cumulative cases reported in the previous three years. All the cases were treated at health care facilities and are considered out of danger. Algeria is a country in North Africa on the Mediterranean coast. Brucellosis, or Malta fever is considered a “rare” disease in several Mediterranean countries, according...

Continue Reading >

Forex Market Video